Downregulation of the FTO m

Alpha-Ketoglutarate-Dependent Dioxygenase FTO / genetics Animals Down-Regulation / genetics Epithelial-Mesenchymal Transition / genetics Humans Mice Neoplasms, Glandular and Epithelial RNA

Journal

Nature cancer

ISSN: 2662-1347

Titre abrégé: Nat Cancer

Pays: England

ID NLM: 101761119

Informations de publication

Date de publication:
06 2021

Historique:

received: 12 06 2019

accepted: 17 05 2021

entrez: 5 2 2022

pubmed: 6 2 2022

medline: 12 4 2022

Statut: ppublish

Résumé

Post-transcriptional modifications of RNA constitute an emerging regulatory layer of gene expression. The demethylase fat mass- and obesity-associated protein (FTO), an eraser of N

Identifiants

DOI: 10.1038/s43018-021-00223-7 PMID: 35121941

pubmed: 35121941

doi: 10.1038/s43018-021-00223-7

pii: 10.1038/s43018-021-00223-7

doi:

Substances chimiques

RNA 63231-63-0

FTO protein, mouse EC 1.14.11.-

Alpha-Ketoglutarate-Dependent Dioxygenase FTO EC 1.14.11.33

FTO protein, human EC 1.14.11.33

Banques de données

figshare

['10.6084/m9.figshare.14602932', '10.6084/m9.figshare.14602944', '10.6084/m9.figshare.14602953', '10.6084/m9.figshare.14602965', '10.6084/m9.figshare.14602971', '10.6084/m9.figshare.14602986']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

Pagination

611-628

Subventions

Organisme : NIGMS NIH HHS

ID : R01 GM058843

Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Références

Harcourt, E. M., Kietrys, A. M. & Kool, E. T. Chemical and structural effects of base modifications in messenger RNA. Nature 541, 339–346 (2017).

pubmed: 28102265 pmcid: 5498787 doi: 10.1038/nature21351

Boccaletto, P. et al. MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 46, D303–D307 (2018).

Dominissini, D. et al. Topology of the human and mouse m

pubmed: 22575960 doi: 10.1038/nature11112

Meyer, K. D. et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell 149, 1635–1646 (2012).

pubmed: 22608085 pmcid: 3383396 doi: 10.1016/j.cell.2012.05.003

Shi, H., Wei, J. & He, C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol. Cell 74, 640–650 (2019).

Jia, G. et al. N

pubmed: 22002720 pmcid: 3218240 doi: 10.1038/nchembio.687

Zheng, G. et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol. Cell 49, 18–29 (2013).

pubmed: 23177736 doi: 10.1016/j.molcel.2012.10.015

Deng, X., Su, R., Stanford, S. & Chen, J. Critical enzymatic functions of FTO in obesity and cancer. Front. Endocrinol. 9, 396 (2018).

Geula, S. et al. Stem cells. m

pubmed: 25569111 doi: 10.1126/science.1261417

Meyer, K. D. et al. 5′ UTR m

pubmed: 26593424 pmcid: 4695625 doi: 10.1016/j.cell.2015.10.012

Zhou, J. et al. Dynamic m

pubmed: 26458103 pmcid: 4851248 doi: 10.1038/nature15377

Liu, N. et al. N

pubmed: 25719671 pmcid: 4355918 doi: 10.1038/nature14234

Yue, Y., Liu, J. & He, C. RNA N

pubmed: 26159994 pmcid: 4511210 doi: 10.1101/gad.262766.115

Fu, Y., Dominissini, D., Rechavi, G. & He, C. Gene expression regulation mediated through reversible m

pubmed: 24662220 doi: 10.1038/nrg3724

Li, Z. et al. FTO plays an oncogenic role in acute myeloid leukemia as a N

pubmed: 28017614 doi: 10.1016/j.ccell.2016.11.017

Su, R. et al. R-2HG exhibits anti-tumor activity by targeting FTO/m

pubmed: 29249359 doi: 10.1016/j.cell.2017.11.031

Vu, L. P. et al. The N

pubmed: 28920958 pmcid: 5677536 doi: 10.1038/nm.4416

Huang, Y. et al. Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia. Cancer Cell 35, 677–691 (2019).

Su, R. et al. Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell 38, 79–96 (2020).

Cui, Q. et al. m

pubmed: 28297667 pmcid: 5479356 doi: 10.1016/j.celrep.2017.02.059

Yang, S. et al. m

Zhuang, C. et al. N

pubmed: 30648791 pmcid: 6378205 doi: 10.1111/jcmm.14128

Rong, Z. X. et al. Downregulation of fat mass and obesity associated (FTO) promotes the progression of intrahepatic cholangiocarcinoma. Front. Oncol. 9, 369 (2019).

Wen, L., Pan, X., Yu, Y. & Yang, B. Down-regulation of FTO promotes proliferation and migration, and protects bladder cancer cells from cisplatin-induced cytotoxicity. BMC Urol. 20, 39 (2020).

Niu, Y. et al. RNA N

pubmed: 30922314 pmcid: 6437932 doi: 10.1186/s12943-019-1004-4

Wu, L., Wu, D., Ning, J., Liu, W. & Zhang, D. Changes of N

pubmed: 30953473 pmcid: 6451293 doi: 10.1186/s12885-019-5538-z

Xu, Y. et al. The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer. Cancer Commun. 40, 484–500 (2020).

Peitzsch, C., Tyutyunnykova, A., Pantel, K. & Dubrovska, A. Cancer stem cells: the root of tumor recurrence and metastases. Semin. Cancer Biol. 44, 10–24 (2017).

pubmed: 28257956 doi: 10.1016/j.semcancer.2017.02.011

Moro, M. et al. Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness. Sci. Rep. 7, 6689 (2017).

pubmed: 28751748 pmcid: 5532258 doi: 10.1038/s41598-017-06912-7

Huang, Y. et al. Meclofenamic acid selectively inhibits FTO demethylation of m

pubmed: 25452335 doi: 10.1093/nar/gku1276

Gil-Rendo, A. et al. Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer. Br. J. Surg. 96, 166–170 (2009).

pubmed: 19160365 doi: 10.1002/bjs.6459

Groheux, D., Espié, M., Giacchetti, S. & Hindié, E. Performance of FDG PET/CT in the clinical management of breast cancer. Radiology 266, 388–405 (2012).

pubmed: 23220901 doi: 10.1148/radiol.12110853

Angeloni, V., Tiberio, P., Appierto, V. & Daidone, M. G. Implications of stemness-related signaling pathways in breast cancer response to therapy. Semin. Cancer Biol. 31, 43–51 (2015).

pubmed: 25153354 doi: 10.1016/j.semcancer.2014.08.004

Velloso, F. J. et al. The crossroads of breast cancer progression: insights into the modulation of major signaling pathways. Onco. Targets Ther. 10, 5491–5524 (2017).

pubmed: 29200866 pmcid: 5701508 doi: 10.2147/OTT.S142154

Zhou, S. et al. FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation. Mol. Carcinog. 57, 590–597 (2018).

pubmed: 29315835 doi: 10.1002/mc.22782

Hu, B. et al. Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth. Cell 167, 1281–1295 (2016).

pubmed: 27863244 pmcid: 5320931 doi: 10.1016/j.cell.2016.10.039

Mikels, A. J. & Nusse, R. Purified Wnt5a protein activates or inhibits β-catenin–TCF signaling depending on receptor context. PLoS Biol. 4, e115 (2006).

Hung, T. H. et al. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway. Oncotarget 5, 12273–12290 (2014).

Veeman, M. T., Axelrod, J. D. & Moon, R. T. A second canon: functions and mechanisms of β-catenin-independent Wnt signaling. Dev. Cell 5, 367–377 (2003).

pubmed: 12967557 doi: 10.1016/S1534-5807(03)00266-1

Desmedt, C. et al. Genomic characterization of primary invasive lobular breast cancer. J. Clin. Oncol. 34, 1872–1881 (2016).

Bartosovic, M. et al. N

pubmed: 28977517 pmcid: 5737695 doi: 10.1093/nar/gkx778

Ji, Z., Lee, J. Y., Pan, Z., Jiang, B. & Tian, B. Progressive lengthening of 3′ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc. Natl Acad. Sci. USA 106, 7028–7033 (2009).

pubmed: 19372383 pmcid: 2669788 doi: 10.1073/pnas.0900028106

Gonsalves, F. C. et al. An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc. Natl Acad. Sci. USA 108, 5954–5963 (2011).

pubmed: 21393571 pmcid: 3076864 doi: 10.1073/pnas.1017496108

Tan, A., Dang, Y., Chen, G. & Mo, Z. Overexpression of the fat mass and obesity associated gene (FTO) in breast cancer and its clinical implications. Int. J. Clin. Exp. Pathol. 8, 13405–13410 (2015).

pubmed: 26722548 pmcid: 4680493

Pastushenko, I. et al. Identification of the tumour transition states occurring during EMT. Nature 556, 463–468 (2018).

pubmed: 29670281 doi: 10.1038/s41586-018-0040-3

Zhang, Y. & Weinberg, R. A. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front. Med. 12, 361–373 (2018).

pubmed: 30043221 pmcid: 6186394 doi: 10.1007/s11684-018-0656-6

Lin, X. et al. RNA m

pubmed: 31061416 pmcid: 6502834 doi: 10.1038/s41467-019-09865-9

Rao, V. K. et al. Phosphorylation of Tet3 by cdk5 is critical for robust activation of BRN2 during neuronal differentiation. Nucleic Acids Res. 48, 1225–1238 (2020).

Shi, F. T. et al. Ten-eleven translocation 1 (Tet1) is regulated by O-linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells. J. Biol. Chem. 288, 20776–20784 (2013).

Blaschke, K. et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 500, 222–226 (2013).

Losman, J. A. & Kaelin, W. G. What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev. 27, 836–852 (2013).

Beerling, E. et al. Plasticity between epithelial and mesenchymal states unlinks EMT from metastasis-enhancing stem cell capacity. Cell Rep. 14, 2281–2288 (2016).

Liu, J. et al. Landscape and regulation of m

Clevers, H. & Nusse, R. Wnt/β-catenin signaling and disease. Cell 149, 1192–1205 (2012).

Pai, S. G. et al. Wnt/β-catenin pathway: modulating anticancer immune response. J. Hematol. Oncol. 10, 101 (2017).

pubmed: 28476164 pmcid: 5420131 doi: 10.1186/s13045-017-0471-6

Mukherjee, N. & Panda, C. K. Wnt/β-catenin signaling pathway as chemotherapeutic target in breast cancer: an update on pros and cons. Clin. Breast Cancer 20, 361–370 (2020).

Tian, T. V. et al. Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2. Oncogene 33, 2204–2214 (2014).

pubmed: 23708657 doi: 10.1038/onc.2013.176

Yuan, B. F. Liquid chromatography–mass spectrometry for analysis of RNA adenosine methylation. Methods Mol. Biol. 1562, 33–42 (2017).

Ross, R., Cao, X., Yu, N. & Limbach, P. A. Sequence mapping of transfer RNA chemical modifications by liquid chromatography tandem mass spectrometry. Methods 107, 73–78 (2016).

pubmed: 27033178 pmcid: 5014671 doi: 10.1016/j.ymeth.2016.03.016

Lánczky, A. et al. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res. Treat. 160, 439–446 (2016).

Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346–352 (2012).

pubmed: 22522925 pmcid: 3440846 doi: 10.1038/nature10983

Varambally, S. et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8, 393–406 (2005).

Rokavec, M., Kaller, M., Horst, D. & Hermeking, H. Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression. Sci. Rep. 7, 4687 (2017).

Chen, S. et al. AfterQC: automatic filtering, trimming, error removing and quality control for fastq data. BMC Bioinformatics 18, 80 (2017).

Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).

Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).

pubmed: 23104886 doi: 10.1093/bioinformatics/bts635

Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).

Anders, S., Pyl, P. T. & Huber, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).

Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).

Lee, J. Y., Yeh, I., Park, J. Y. & Tian, B. PolyA_DB 2: mRNA polyadenylation sites in vertebrate genes. Nucleic Acids Res. 35, D165–D168 (2007).

Zhang, Y. et al. Model-based analysis of ChIP–seq (MACS). Genome Biol. 9, R137 (2008).

Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).

Bailey, T. L. et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202–W208 (2009).

Veeman, M. T., Slusarski, D. C., Kaykas, A., Louie, S. H. & Moon, R. T. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr. Biol. 13, 680–685 (2003).

pubmed: 12699626 doi: 10.1016/S0960-9822(03)00240-9

Metzger-Filho, O. et al. Genomic grade adds prognostic value in invasive lobular carcinoma. Ann. Oncol. 24, 377–384 (2013).

Van Grembergen, O. et al. Portraying breast cancers with long noncoding RNAs. Sci. Adv. 2, e1600220 (2016).